Development of an improved vaccine for anthrax.
Leppla
Stephen H
SH
National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland 20892-4350, USA. Leppla@nih.gov
Robbins
John B
JB
Schneerson
Rachel
R
Shiloach
Joseph
J
D000818:Animals; D000881:Anthrax / Q000276:immunology / Q000517:prevention & control; D022122:Anthrax Vaccines / Q000302:isolation & purification* / Q000592:standards; D000907:Antibodies, Bacterial / Q000096:biosynthesis; D000942:Antigens, Bacterial; D000992:Antitoxins / Q000276:immunology; D001408:Bacillus anthracis / Q000276:immunology / Q000472:pathogenicity; D001427:Bacterial Toxins / Q000737:chemistry / Q000276:immunology; D006801:Humans; D008958:Models, Molecular; D009500:Neutralization Tests; D012015:Reference Standards; D013171:Spores, Bacterial / Q000276:immunology
D022122:Anthrax Vaccines; D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D000992:Antitoxins; D001427:Bacterial Toxins; C030325:anthrax toxin